Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-23

Clinical Trial Update: Aprepitant Effects on Oxycodone Response [NA]

View source ↗

Summary

Clinical trial examining how the NK1 receptor antagonist aprepitant affects oxycodone response in individuals with opioid use disorder. The study completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aprepitant (aprepitant)
  • Oxycodone (oxycodone)

Snippet

Sponsor: Sharon Walsh | Conditions: Narcotic Abuse | NA | Status: COMPLETED | Results posted: 2013-08-23